nintedanib

FDA Drug Profile — Ofev, Nintedanib, nintedanib

nintedanib is listed in the FDA National Drug Code directory with 18 NDC codes, marketed under brand names including Ofev, Nintedanib, nintedanib. Available dosage form: capsule.

Drug details

Generic Name
nintedanib
Brand Names
Ofev, Nintedanib, nintedanib
Application Number
NDA205832
Sponsor
Boehringer Ingelheim Pharmaceuticals, Inc.
NDC Codes
18
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
NINTEDANIB ESYLATE

Indications and Usage

1 INDICATIONS AND USAGE Nintedanib Capsules is a kinase inhibitor indicated in adults for: Treatment of idiopathic pulmonary fibrosis (IPF) ( 1.1 ) Treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype ( 1.2 ) 1.1 Idiopathic Pulmonary Fibrosis Nintedanib Capsules is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF). 1.2 Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype Nintedanib Capsules is indicated for the treatment of adults with chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype [see Clinical Studies (14.2) ].

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.